- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT04473534
Web Based CBT-I in Patients With OSA and Insomnia
September 28, 2023 updated by: Istituti Clinici Scientifici Maugeri SpA
Web Based Cognitive-behavioral Therapy in Patients With Obstructive Sleep Apnoea Syndrome and Insomnia: a Randomized Clinical Trial
Obstructive sleep apnea (OSA) and insomnia often occur in the same patient.
Recent studies have demonstrated the efficacy of cognitive behavioral therapy (CBT-I) in patients with insomnia and OSA.
Our aim is to verify the efficacy of web based CBT-I in patients with OSA and insomnia and the effect of web based CBT-I on the acceptance and adherence to CPAP (Continuous Positive Airway Pressure) therapy.
Study Overview
Status
Withdrawn
Conditions
Intervention / Treatment
Detailed Description
Obstructive sleep apnea is one of the most common sleep disorders with high prevalence in males sex, is often associated with insomnia.
The presence of both sleep disorders generates a vicious circle that exacerbates the clinical picture, makes difficult to accept and adhere to CPAP therapy and increase cardiovascular risk.
CBT-I is considered the best treatment for insomnia and recent research has demonstrated the efficacy of CBT-I also when insomnia is associated with OSA.
After six month of treatment we will test the efficacy of web-based CBT-I in patients with OSA and insomnia in comparison to one session of psycho education on sleep, OSA, insomnia, the interaction among them and the influence on CPAP adherence.
Study Type
Interventional
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Novara
-
Veruno, Novara, Italy, 28013
- Fabio Rossato
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years to 80 years (Adult, Older Adult)
Accepts Healthy Volunteers
No
Description
Inclusion Criteria:
- Age ≥18
- Apnea-Hypopnea Index (AHI) ≥5
Exclusion Criteria:
- Complex sleep apnea
- AHI >35
- Psychiatric comorbidies
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Arm of CBT-I treatment
Web cognitive behavioral therapy was administered before starting CPAP use by a psychologist expert in behavioral sleep medicine and expert in CBT-I.
CBT-I was administered according to the same model and standard visual approach in patients with insomnia.
Five sessions are scheduled: sleep psycho-education, sleep restriction, stimulus control, sleep hygiene and challenging beliefs and perception of sleep.
|
one web session of psycho-education about sleep
Other Names:
|
|
Experimental: Arm of psycho-education session
Single session of psycho-education about sleep, OSA, insomnia and interaction among them will be administered by web before beginning CPAP use
|
one web session of psycho-education about sleep
Other Names:
|
|
No Intervention: Arm of control TAU (Treatment As Usual)
The control group will receive TAU.
Each patient will start to use CPAP after the diagnosis according to AASM (American Academy of Sleep Medicine) guideline.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Insomnia Severity
Time Frame: Baseline
|
Assessed by Insomnia Severity Index
|
Baseline
|
|
Insomnia Severity
Time Frame: six months of CPAP use
|
Assessed by Insomnia Severity Index
|
six months of CPAP use
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Adherence to CPAP therapy
Time Frame: six months of use
|
Hours of CPAP use during sleep with download of data
|
six months of use
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Publications and helpful links
The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.
General Publications
- Sweetman A, Lack L, Catcheside PG, Antic NA, Smith S, Chai-Coetzer CL, Douglas J, O'grady A, Dunn N, Robinson J, Paul D, Williamson P, McEvoy RD. Cognitive and behavioral therapy for insomnia increases the use of continuous positive airway pressure therapy in obstructive sleep apnea participants with comorbid insomnia: a randomized clinical trial. Sleep. 2019 Dec 24;42(12):zsz178. doi: 10.1093/sleep/zsz178.
- Sweetman A, McEvoy RD, Smith S, Catcheside PG, Antic NA, Chai-Coetzer CL, Douglas J, O'Grady A, Dunn N, Robinson J, Paul D, Williamson P, Lack L. The effect of cognitive and behavioral therapy for insomnia on week-to-week changes in sleepiness and sleep parameters in patients with comorbid insomnia and sleep apnea: a randomized controlled trial. Sleep. 2020 Jul 13;43(7):zsaa002. doi: 10.1093/sleep/zsaa002.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Estimated)
March 10, 2021
Primary Completion (Estimated)
December 31, 2021
Study Completion (Estimated)
March 30, 2022
Study Registration Dates
First Submitted
July 10, 2020
First Submitted That Met QC Criteria
July 15, 2020
First Posted (Actual)
July 16, 2020
Study Record Updates
Last Update Posted (Actual)
September 29, 2023
Last Update Submitted That Met QC Criteria
September 28, 2023
Last Verified
February 1, 2021
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 2361
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
NO
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Insomnia
-
Christoph NissenRecruitingInsomnia | Insomnia Chronic | Insomnia Disorder | Insomnia, Primary | Insomnia Type; Sleep Disorder | Insomnia Disorders | Insomnia, NonorganicSwitzerland
-
University of PennsylvaniaPatient-Centered Outcomes Research InstituteNot yet recruitingInsomnia | Chronic Insomnia | Insomnia Disorder | Chronic Insomnia DisorderUnited States
-
National Yang Ming UniversityBened Biomedical Co., Ltd.Recruiting
-
Leiden University Medical CenterCompleted
-
Shanghai Haiyan Pharmaceutical Technology Co.,...Active, not recruiting
-
Weill Medical College of Cornell UniversityMARPACCompleted
-
Regenstrief Institute, Inc.Merck Sharp & Dohme LLC; National Sleep FoundationUnknownInsomniaUnited States
-
Posit Science CorporationUniversity of California, San FranciscoCompleted
-
University of UtahNational Center for Complementary and Integrative Health (NCCIH)Completed
-
Minneapolis Veterans Affairs Medical CenterWithdrawn
Clinical Trials on web based cognitive-behavioral therapy
-
Stanford UniversityCompletedDepression | Systemic Lupus Erythematosus | Anxiety | Juvenile Idiopathic Arthritis | Inflammatory Bowel Disease
-
Wake Forest University Health SciencesNational Center for Advancing Translational Sciences (NCATS)CompletedChronic Musculoskeletal PainUnited States
-
Shanghai Mental Health CenterCompletedFeeding and Eating DisordersChina
-
Brigham and Women's HospitalActive, not recruiting
-
Tilburg UniversityErasmus Medical Center; Catharina Ziekenhuis Eindhoven; Onze Lieve Vrouwe Gasthuis and other collaboratorsUnknownHeart Diseases | Implantable Cardioverter-DefibrillatorsNetherlands
-
Emory UniversityNational Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)TerminatedDiabetes Mellitus, Type 2United States
-
Brigham and Women's HospitalThe Cleveland ClinicCompleted
-
CHU de Quebec-Universite LavalCanadian Institutes of Health Research (CIHR)Completed
-
Mount Sinai Hospital, CanadaUnknownDepression | Inflammatory Bowel Diseases | Anxiety | Crohn Disease | Ulcerative ColitisCanada
-
Emory UniversityAlzheimer's AssociationCompleted